Engineering a Therapeutic Protein to Enhance the Study of Anti-Drug Immunity

Engineering a Therapeutic Protein to Enhance the Study of Anti-Drug Immunity

The development of anti-drug antibodies represents a significant barrier to the utilization of protein-based therapies for a wide variety of diseases. While the rate of antibody formation can vary depending on the therapeutic employed and the target patient population receiving the drug, the antigen...

Full description

Bibliographic Details
Main Authors:	Patricia E. Zerra, Ernest T. Parker, Wallace Hunter Baldwin, John F. Healey, Seema R. Patel, James W. McCoy, Courtney Cox, Sean R. Stowell, Shannon L. Meeks
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Biomedicines
Subjects:	anti-drug antibodies hemophilia A factor VIII inhibitors humoral immunity
Online Access:	https://www.mdpi.com/2227-9059/10/7/1724

Similar Items

Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner
by: Glaivy Batsuli, et al.
Published: (2023-08-01)

Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway
by: Seema R. Patel, et al.
Published: (2022-05-01)

Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation
by: Patricia E. Zerra, et al.
Published: (2020-06-01)

Development of inhibitors in hemophilia A: An illustrated review
by: Letícia Lemos Jardim, et al.
Published: (2020-07-01)

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status
by: Glaivy Batsuli, et al.
Published: (2021-02-01)

Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors
by: Claude Négrier, et al.
Published: (2022-05-01)

“Prevalence of Inhibitors in Hemophilia Patients and its Clinical Implications”: A Study of 276 Patients in Western India
by: Sangita Darshan Shah, et al.
Published: (2019-01-01)

Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
by: Volkan Karakuş, et al.
Published: (2012-05-01)

Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with Inhibitors
by: Shuichi Okamoto, et al.
Published: (2019-10-01)

Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications
by: Liping Luo, et al.
Published: (2022-12-01)

Surgery-associated acquired hemophilia A: a report of 2 cases and review of literature
by: Umar Zeb Khan, et al.
Published: (2020-09-01)

Recombinant porcine factor VIII: Lessons from the past and place in the management of hemophilia A with inhibitors in 2021
by: Yesim Dargaud, et al.
Published: (2021-12-01)

Acquired factor VIII inhibitor syndrome: A rare cause of hematuria
by: Muthuvel Seral Kannan, et al.
Published: (2015-01-01)

Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations
by: Farzaneh Nasirnejad Sola, et al.
Published: (2020-12-01)

Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report
by: Beth Boulden Warren, et al.
Published: (2021-07-01)

HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdataset
by: Joseph R. McGill, et al.
Published: (2021-05-01)

Acquired factor VIII inhibitor associated with chronic untreated hepatitis C
by: Abdussalam Shredi, et al.
Published: (2018-04-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

Genetic Characterization of the Factor VIII Gene in a Cohort of Colombian Patients with Severe Hemophilia A with Inhibitors
by: Samuel Sarmiento Doncel, et al.
Published: (2022-05-01)

A case of acquired hemophilia A in an elderly female
by: Kiranveer Kaur, et al.
Published: (2018-07-01)

A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy
by: Alex C. Chen, et al.
Published: (2020-04-01)

Bullous Pemphigoid Associated with Acquired Hemophilia A: A Case Report and Review of the Literature
by: Wuttidej Fakprapai, et al.
Published: (2019-05-01)

Hemophilia A - acquired during coronary artery bypass grafting
by: Akintorin Abayomi, et al.
Published: (2013-01-01)

Immunogenicity of Current and New Therapies for Hemophilia A
by: Alessandra N. L. Prezotti, et al.
Published: (2022-07-01)

Desenvolvimento de inibidores do fator VIII na hemofilia A Development of factor VIII inhibitors in hemophilia A
by: Daniel G. Chaves, et al.
Published: (2009-01-01)

Clinical and Laboratory Approaches to Hemophilia A
by: Hassan Mansouritorghabeh
Published: (2015-05-01)

Anesthesia Concerns and Management in Case of Severe Hemophilia A: A Case Report and Review of Literature
by: Deepali Jamgade, et al.
Published: (2022-01-01)

Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea
by: Byung Suk Moon, et al.
Published: (2013-07-01)

A case of subdural hematoma with a medical history of hemophilia a and a review of related literature
by: Yi Zhao, et al.
Published: (2018-05-01)

Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia
by: Midori Shima
Published: (2020-05-01)

Coexistence of Acquired Hemophilia and Antiphospholipid Serology in Monoclonal Gammopathy Patient
by: Belfeki N, et al.
Published: (2021-04-01)

Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
by: Maria T. Georgescu, et al.
Published: (2020-02-01)

Parapharyngeal hematoma following transesophageal echo in a patient with hemophilia A
by: Dominic McKenna, et al.
Published: (2023-06-01)

Repression of factor VIII inhibitor development with apoptotic factor VIII-expressing embryonic stem cells
by: Yoshihiko Sakurai, et al.
Published: (2013-07-01)

Hemodialysis access in a patient with severe hemophilia: Technical challenges
by: Murali Manivannan, et al.
Published: (2018-01-01)

Congenital hemophilia A with low activity of factor XII: a case report and literature review
by: Baoyu Lei, et al.
Published: (2021-10-01)

Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?
by: Laila M. Sherief, et al.
Published: (2020-09-01)

Obtenção e caracterização de anticorpo monoclonal murino anti-fator VIII da coagulação sangüínea Attainment and characterization of murine monoclonal anti-factor VIII antibodies
by: Rosana Rossi-Ferreira, et al.
Published: (2006-06-01)

The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A
by: Ilja Oomen, et al.
Published: (2024-02-01)

Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement
by: Margareth Castro Ozelo, et al.
Published: (2024-01-01)